ACR Attends 2025 RUC Meetings
ACR participated in the American Medical Association/Specialty Society RVS Update Committee meeting where they heard updates on the AMA Physician Practice Information Survey.
Read moreThe U.S. Food and Drug Administration (FDA) seeks public comments on draft guidance it published Jan. 7. Of particular interest to the American College of Radiology® (ACR®) is “Artificial Intelligence (AI)-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations.”
The industry guidance outlines a total product lifecycle (TPLC) approach to risk management of AI device software functions, as well as related documentation to support FDA review. It also provides recommendations relevant to transparency and bias mitigation throughout the TPLC, including within the product’s user interface and labelling.
The ACR Informatics Commission and Data Science Institute® (DSI) leadership are reviewing the guidance. The College’s initiatives related to AI are on the DSI website.
Public comments are due to the FDA by April 7.
If you have questions or would like more information about ACR AI/digital health policy, contact Michael Peters, ACR Senior Director, Government Affairs.
ACR Attends 2025 RUC Meetings
ACR participated in the American Medical Association/Specialty Society RVS Update Committee meeting where they heard updates on the AMA Physician Practice Information Survey.
Read moreNCI Releases FY 2027 Budget Proposal
Anthony Letai, MD, PhD, became NCI Director Sept. 29, leading with a $7.2B budget and proposing $11.5B for FY 2027 to boost cancer research.
Read moreLead the Future of Alzheimer's Imaging
Join ALZ-NET Imaging Network to access AI tools, boost Alzheimer’s imaging, and contribute data to shape FDA safety and clinical guidelines.
Read more